Skip to Main Navigation

Second Additional Financing for Third Partnership for Polio Eradication Project

Development Objective

The project will assist the Government of Pakistan's Polio Eradication Initiative in decreasing the number of polio cases and ultimately eradicating the disease in Pakistan. The development objective is to assist Pakistan's efforts to eradicate polio through supply of the Oral Polio Vaccine for the country's supplementary immunization activities during 2009-11.

Key Details

Project Details

  • P132541

  • Closed

  • Tayyeb Masud

  • N/A

  • Pakistan

  • August 6, 2012

  • (as of board presentation)

    October 2, 2012

  • N/A

  • US$ 24.00 million

  • C

  • Not Applicable

  • June 30, 2014

  • BANK APPROVED

  • P114508

  • January 15, 2013

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 24.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 24.00
IBRD + IDA Commitment 24.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 24.00

Summary Status of World Bank Financing (US$ Millions) as of July 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of July 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)

Footnotes

Ratings

IMPLEMENTATION RATINGS

No data available.

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • OPV coverageValue0.000.000.00
    Date
    Comment
  • Children immunized (number)Value0.000.000.00
    DateJanuary 30, 2013
    Comment
  • Children immunized - under 5 years against Polio (number)Value0.000.000.00
    DateJanuary 30, 2013
    CommentChildren immunized per campaign
  • High Risk OPV coverageValue0.000.000.00
    Date
    Comment
  • Number of confirmed polio cases reported per yearValue0.000.000.00
    Date
    Comment
  • Vitamin A coverageValue0.000.000.00
    Date
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Arrival of OPVValue0.000.000.00
    Date
    Comment
  • procurementValue0.000.000.00
    Date
    Comment